Globeflex Capital L P Champions Oncology, Inc. Transaction History

Globeflex Capital L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$4.11 - $6.81 $12,268 - $20,327	-2,985 Reduced 34.92%	5,564 $35,000
Q4 2020 Feb 11, 2021	SELL	$8.39 - $13.27 $208,843 - $330,316	-24,892 Reduced 74.44%	8,549 $92,000
Q3 2020 Nov 13, 2020	SELL	$7.05 - $10.2 $21,798 - $31,538	-3,092 Reduced 8.46%	33,441 $309,000
Q2 2020 Aug 12, 2020	BUY	$6.65 - $9.84 $88,079 - $130,330	13,245 Added 56.87%	36,533 $349,000
Q1 2020 May 13, 2020	BUY	$4.19 - $8.62 $97,576 - $200,742	23,288 New	23,288 $172,000

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.